Discover our new M*Detect product for digital PCR !
MDetect kits from METHYS Dx are based on proprietary methylation signatures and are compatible with commercially available digital PCR instruments. MDetect kits are used to analyze circulating tumor DNA from patients with advanced cancers (stages III–IV). Thanks to the use of digital PCR, results can be obtained within a single day.
Our tests are based on liquid biopsies, and target the analysis of certain types of biomarkers, present in biological fluids, such as blood. METHYS Dx develops panels of methylation markers, in order to characterize circulating tumor DNA (ctDNA) within liquid biopsies. The tests developped by METHYS Dx will thus be used to establish prognosis, monitor tumor evolution, and allow the early detection of relapses.
The tests developped by METHYS Dx target different cancer types, amongst the most frequent. These tests are based on a novel detection technology, and present an efficient and less-costly alternative to NGS tests. METHYS Dx tests can also be used for quality control of results obtained using other technologies (NGS or digital PCR for example).
Innovation
Precision & Reliability
Passion
METHYS Dx services activities and R&D program are based for a large part on research carried out within the MEPPOT and SPM laboratories. You may browse through the original publications of their work in this section.
✨ A memorable VivaTech for METHYS Dx! We were honored to see Valerie Taly be awarded a Business O Féminin Award on Thursday, June 18th 🏆, a meaningful recognition of her commitment to driving innovation in healthcare. 👏Congratulations as well to the other award recipients : Manel Chikh – My Bubble Health, Sandra Kamdeu – […]
> Know more
Magali Droniou and Valerie Taly had the pleasure of representing METHYS Dx at Nexus Luxembourg 2026 as part of the Girls & Tech delegation. 🙏 We are very grateful to Women in Business NI (WIB), its members and sponsors, as well as to Girls & Tech for giving us the opportunity to pitch during this […]
> Know more